3.3.11 Pregnancy prevention programmes

• What is the primary purpose of Pregnancy Prevention Programmes (PPP) for certain medicines?

     A) To promote pregnancy

     B) To minimise the risk of pregnancy while taking the medicines

     C) To increase the risk of spontaneous abortion

     D) To provide free contraception

  To minimise the risk of pregnancy while taking the medicines
• Which of the following medicines are NOT mentioned as carrying a high risk of causing foetal malformations?

     A) Aspirin

     B) Oral retinoids

     C) Valproate

     D) Lenalidomide

  Aspirin
• According to the Summary of Product Characteristics (SPCs), what is the status of oral retinoids during pregnancy?

     A) They are safe during any trimester

     B) They should be used cautiously in the third trimester

     C) They are contraindicated in pregnant women

     D) They are recommended in the first trimester

  They are contraindicated in pregnant women
• Who can initiate oral retinoid therapy according to the provided information?

     A) Any healthcare professional

     B) Pharmacists only

     C) Dermatologist or specialised healthcare professionals

     D) Patients themselves

  Dermatologist or specialised healthcare professionals
• What is a key component of the Pregnancy Prevention Programme for oral retinoids?

     A) Monthly blood tests

     B) Pregnancy testing before, during, and after treatment

     C) Regular ultrasound scans

     D) Hormonal therapy

  Pregnancy testing before, during, and after treatment
• How often should the patient be followed up under the Pregnancy Prevention Programme for oral retinoids?

     A) Quarterly

     B) Annually

     C) Monthly

     D) Bi-annually

  Monthly
• What is the maximum duration of validity for prescriptions under the PPP for oral retinoids?

     A) 14 days

     B) 30 days

     C) 7 days

     D) 90 days

  7 days
• Under the PPP, what action should be taken if a prescription for oral retinoids is presented after seven days?

     A) The prescription should be filled immediately

     B) The prescription should be considered expired and referred back to the prescriber

     C) The patient should be advised to use it later

     D) The pharmacist should dispense a 14-day supply instead

  The prescription should be considered expired and referred back to the prescriber
• How often should pregnancy status be reconfirmed for patients under the PPP for oral retinoids?

     A) Every 3 months

     B) Every 6 months

     C) Every year

     D) Before each prescription refill

  Before each prescription refill
• Which of the following is NOT a distribution control measure for oral retinoids?

     A) Acceptance of repeat prescriptions

     B) Acceptance of faxed prescriptions

     C) Acceptance of free sample distribution

     D) Acceptance of telephone requests for emergency supply

  Acceptance of free sample distribution
• How long is the quantity of oral retinoids supply under the PPP valid for?

      A) 60 days

      B) 90 days

      C) 30 days

      D) 45 days

  30 days
• Who should confirm that a patient is not under the PPP for oral retinoids if a quantity for more than 30 days is prescribed?

      A) Pharmacist

      B) Patient's family member

      C) Prescriber

      D) Nurse

  Prescriber
• Which of the following is NOT a role of pharmacists in managing oral retinoids under the PPP?

      A) Ensuring pregnancy testing is conducted

      B) Accepting repeat prescriptions

      C) Referring expired prescriptions back to the prescriber

      D) Ensuring quantity supplied is not more than 30 days

  Accepting repeat prescriptions
• What should be done if a patient presents a prescription for oral retinoids after the seven-day validity period?

      A) Fill the prescription with a 14-day supply

      B) Refill the prescription without any action

      C) Consider the prescription expired and refer the patient back to the prescriber

      D) Dispense a 30-day supply

  Consider the prescription expired and refer the patient back to the prescriber
• How often should the patient be followed up under the Pregnancy Prevention Programme for oral retinoids?

      A) Every month

      B) Every 3 months

      C) Every 6 months

      D) Once a year

  Every month
• Which healthcare professionals can initiate oral retinoid therapy under the PPP?

      A) Only dermatologists

      B) Any healthcare professional

      C) General practitioners

      D) Pharmacists

  Only dermatologists
• What is the prescription validity period under the PPP for oral retinoids?

      A) 14 days

      B) 30 days

      C) 7 days

      D) 60 days

  7 days
• What should pharmacists do if a prescription for oral retinoids is presented after the seven-day validity period?

      A) Fill the prescription immediately

      B) Consider the prescription expired and refer the patient back to the prescriber

      C) Refill the prescription without any action

      D) Dispense a 14-day supply

  Consider the prescription expired and refer the patient back to the prescriber
• How often should the patient's pregnancy status be confirmed under the PPP for oral retinoids?

      A) Every 3 months

      B) Every 6 months

      C) Before each prescription refill

      D) Annually

  Before each prescription refill
• Which of the following is NOT a distribution control measure for oral retinoids?

      A) Acceptance of faxed prescriptions

      B) Acceptance of repeat prescriptions

      C) Acceptance of free sample distribution

      D) Acceptance of telephone requests for emergency supply

  Acceptance of free sample distribution